ProfileGDS4095 / 220129_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 34% 29% 36% 26% 27% 36% 39% 37% 43% 33% 39% 41% 42% 42% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.501534
GSM709769LY2 SRC1-siRNA tamoxifen treated rep32.3146129
GSM709765LY2 SRC1-siRNA untreated rep32.5923636
GSM709771LY2 SRC1-siRNA untreated rep12.2240226
GSM709772LY2 SRC1-siRNA untreated rep22.2618227
GSM709775LY2 SRC1-siRNA untreated rep42.58236
GSM709764LY2 control-siRNA tamoxifen treated rep22.7487439
GSM709766LY2 control-siRNA tamoxifen treated rep32.6580137
GSM709768LY2 control-siRNA tamoxifen treated rep12.9425743
GSM709777LY2 control-siRNA tamoxifen treated rep42.4571833
GSM709770LY2 control-siRNA untreated rep32.6977439
GSM709773LY2 control-siRNA untreated rep12.8082841
GSM709774LY2 control-siRNA untreated rep22.8660442
GSM709776LY2 control-siRNA untreated rep42.8724542